Ahmed Ali Siddiqui received 38,334 shares, Ebrahim Yakoob received 28,333 shares, Faiz Ur Rehman received 30,000 shares (MEBL)
Filed as: Insider Transaction
Summary
Ahmed Ali Siddiqui received 38,334 shares, Ebrahim Yakoob received 28,333 shares, Faiz Ur Rehman received 30,000 shares, Irfan Siddiqui received 131,668 shares, Khalid Zaman Khan received 43,334 shares, Muhammad Abdullah received 23,334 shares, Muhammad Farhan Ul Haq Usmani received 28,334 shares, Muhammad Raza received 23,334 shares, Muhammad Sohail Khan received 20,000 shares, Muhammad Umar Khan Fareedy received 11,666 shares, Shahzad Abdullah received 43,334 shares, Shariq Mubeen received 28,332 shares, Syed Fahd Azam received 20,000 shares, Shayan Baig received 23,333 shares, Syed Tanveer Hussain received 58,333 shares, Syed Tariq Hassan received 48,332 shares, Urooj Ul Hasan Khan received 48,332 shares, and Zia Ul Hassan received 61,000 shares, all at a rate of Rs 557.07 per share under the ESOS on July 8, 2026.
Read the original filingTransactions disclosed
| Person | Transaction | Shares | Price | Date |
|---|---|---|---|---|
| Ahmed Ali Siddiqui | EsosTHROUGH CDC market | 13,334 | Rs 557.07 | 8 Jul 2026 |
| Ahmed Ali Siddiqui | EsosTHROUGH CDC market | 15,000 | Rs 557.07 | 8 Jul 2026 |
| Ahmed Ali Siddiqui | EsosTHROUGH CDC market | 10,000 | Rs 557.07 | 8 Jul 2026 |
| Ebrahim Yakoob | EsosTHROUGH CDC market | 10,000 | Rs 557.07 | 8 Jul 2026 |
| Ebrahim Yakoob | EsosTHROUGH CDC market | 10,000 | Rs 557.07 | 8 Jul 2026 |
| Ebrahim Yakoob | EsosTHROUGH CDC market | 8,333 | Rs 557.07 | 8 Jul 2026 |
| Faiz Ur Rehman | EsosTHROUGH CDC market | 15,000 | Rs 557.07 | 8 Jul 2026 |
| Faiz Ur Rehman | EsosTHROUGH CDC market | 15,000 | Rs 557.07 | 8 Jul 2026 |
| Irfan SiddiquiNon-Executive Director | EsosTHROUGH CDC market | 38,334 | Rs 557.07 | 8 Jul 2026 |
| Irfan SiddiquiNon-Executive Director | EsosTHROUGH CDC market | 93,334 | Rs 557.07 | 8 Jul 2026 |
| Khalid Zaman Khan | EsosTHROUGH CDC market | 13,334 | Rs 557.07 | 8 Jul 2026 |
| Khalid Zaman Khan | EsosTHROUGH CDC market | 15,000 | Rs 557.07 | 8 Jul 2026 |
| Khalid Zaman Khan | EsosTHROUGH CDC market | 15,000 | Rs 557.07 | 8 Jul 2026 |
| Muhammad Abdullah | EsosTHROUGH CDC market | 11,668 | Rs 557.07 | 8 Jul 2026 |
| Muhammad Abdullah | EsosTHROUGH CDC market | 11,666 | Rs 557.07 | 8 Jul 2026 |
| Muhammad Farhan Ul Haq Usmani | EsosTHROUGH CDC market | 8,334 | Rs 557.07 | 8 Jul 2026 |
| Muhammad Farhan Ul Haq Usmani | EsosTHROUGH CDC market | 10,000 | Rs 557.07 | 8 Jul 2026 |
| Muhammad Farhan Ul Haq Usmani | EsosTHROUGH CDC market | 10,000 | Rs 557.07 | 8 Jul 2026 |
| Muhammad Raza | EsosTHROUGH CDC market | 11,668 | Rs 557.07 | 8 Jul 2026 |
| Muhammad Raza | EsosTHROUGH CDC market | 11,666 | Rs 557.07 | 8 Jul 2026 |
| Muhammad Sohail Khan | EsosTHROUGH CDC market | 10,000 | Rs 557.07 | 8 Jul 2026 |
| Muhammad Sohail Khan | EsosTHROUGH CDC market | 10,000 | Rs 557.07 | 8 Jul 2026 |
| Muhammad Umar Khan Fareedy | EsosTHROUGH CDC market | 5,000 | Rs 557.07 | 8 Jul 2026 |
| Muhammad Umar Khan Fareedy | EsosTHROUGH CDC market | 6,666 | Rs 557.07 | 8 Jul 2026 |
| Shahzad Abdullah | EsosTHROUGH CDC market | 13,334 | Rs 557.07 | 8 Jul 2026 |
| Shahzad Abdullah | EsosTHROUGH CDC market | 15,000 | Rs 557.07 | 8 Jul 2026 |
| Shahzad Abdullah | EsosTHROUGH CDC market | 15,000 | Rs 557.07 | 8 Jul 2026 |
| Shariq Mubeen | EsosTHROUGH CDC market | 10,000 | Rs 557.07 | 8 Jul 2026 |
| Shariq Mubeen | EsosTHROUGH CDC market | 11,666 | Rs 557.07 | 8 Jul 2026 |
| Shariq Mubeen | EsosTHROUGH CDC market | 6,666 | Rs 557.07 | 8 Jul 2026 |
| Syed Fahd Azam | EsosTHROUGH CDC market | 6,668 | Rs 557.07 | 8 Jul 2026 |
| Syed Fahd Azam | EsosTHROUGH CDC market | 6,666 | Rs 557.07 | 8 Jul 2026 |
| Syed Fahd Azam | EsosTHROUGH CDC market | 6,666 | Rs 557.07 | 8 Jul 2026 |
| Shayan Baig | EsosTHROUGH CDC market | 7,334 | Rs 557.07 | 8 Jul 2026 |
| Shayan Baig | EsosTHROUGH CDC market | 8,333 | Rs 557.07 | 8 Jul 2026 |
| Shayan Baig | EsosTHROUGH CDC market | 7,666 | Rs 557.07 | 8 Jul 2026 |
| Syed Tanveer Hussain | EsosTHROUGH CDC market | 15,000 | Rs 557.07 | 8 Jul 2026 |
| Syed Tanveer Hussain | EsosTHROUGH CDC market | 20,000 | Rs 557.07 | 8 Jul 2026 |
| Syed Tanveer Hussain | EsosTHROUGH CDC market | 23,333 | Rs 557.07 | 8 Jul 2026 |
| Syed Tariq Hassan | EsosTHROUGH CDC market | 15,000 | Rs 557.07 | 8 Jul 2026 |
| Syed Tariq Hassan | EsosTHROUGH CDC market | 16,666 | Rs 557.07 | 8 Jul 2026 |
| Syed Tariq Hassan | EsosTHROUGH CDC market | 16,666 | Rs 557.07 | 8 Jul 2026 |
| Urooj Ul Hasan Khan | EsosTHROUGH CDC market | 15,000 | Rs 557.07 | 8 Jul 2026 |
| Urooj Ul Hasan Khan | EsosTHROUGH CDC market | 16,666 | Rs 557.07 | 8 Jul 2026 |
| Urooj Ul Hasan Khan | EsosTHROUGH CDC market | 16,666 | Rs 557.07 | 8 Jul 2026 |
| Zia Ul Hassan | EsosTHROUGH CDC market | 15,000 | Rs 557.07 | 8 Jul 2026 |
| Zia Ul Hassan | EsosTHROUGH CDC market | 20,000 | Rs 557.07 | 8 Jul 2026 |
| Zia Ul Hassan | EsosTHROUGH CDC market | 26,000 | Rs 557.07 | 8 Jul 2026 |
As disclosed by the company. A purchase or sale by an insider is a fact about that person's holding, not a signal about the share.
Meezan Bank Limited (MEBL) on Nafa
Last price Rs 558.40 · Commercial banks · You can own MEBL shares from your phone.
More MEBL announcements
- NoticeTRANSMISSION OF QUARTERLY REPORT OF MEEZAN BANK LIMITED FOR THE PERIOD ENDED SEPTEMBER 30, 2026
- NoticeNOTICES OF BOOK CLOSURE FOR THE ENTITLEMENT OF 80% INTERIM CASH DIVIDEND FOR SHAREHOLDERS OF MEEZAN BANK
- Financial resultFINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS PERIOD ENDED SEPTEMBER 30, 2026 - MEEZAN BANK LIMITEDMeezan Bank reported a strong financial performance with a net profit of Rs 74.53 billion and revenue of Rs 353.04 billion for the nine months ended September 30, 2026, demonstrating robust growth.
- NoticeNOTICE OF BOARD MEETING AND CLOSED PERIOD - MEEZAN BANK LIMITED
- NoticeCHANGE OF DIRECTORS OF MEEZAN BANK LIMITED
- Insider tradeExecutive of Meezan Bank MrFiled as: Insider Transaction
Source: Meezan Bank Limited's filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.